Intellia Therapeutics (NASDAQ:NTLA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.

Open	$12.12
Close	$12.05
Volume / Avg.	859.60K / 2.53M
Day Range	$11.83 - $12.21
52 Wk Range	11.79 - 34.87
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	21.15%
Days to Cover	9.36

Recent News

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Kaustubh Bagalkote

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

3 Fast-Growing Stocks Analysts See Doubling in Price

Comparing and selecting stocks for investment may involve any number of increasingly complex strategies and approaches, but sometimes simpler is better: targeting a stock with significant upside potential at an

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$12.12
Close	$12.05
Volume / Avg.	859.60K / 2.53M
Day Range	$11.83 - $12.21
52 Wk Range	11.79 - 34.87
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	21.15%
Days to Cover	9.36

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intellia Therapeutics (NTLA) stock?

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Who are Intellia Therapeutics (NTLA) competitors?

Other companies in Intellia Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

Intellia Therapeutics has a consensus price target of $69.24.

What is the current price for Intellia Therapeutics (NTLA)?

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $12.0216 last updated December 24, 2024 at 4:40 PM EST.

Does Intellia Therapeutics (NTLA) pay a dividend?

There are no upcoming dividends for Intellia Therapeutics.

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

Intellia Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Is Intellia Therapeutics (NTLA) going to split?

There is no upcoming split for Intellia Therapeutics.

What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Intellia Therapeutics

Intellia Therapeutics (NTLA) Forecast